| MeSH term | MeSH ID | Detail |
|---|---|---|
| Inflammation | D007249 | 119 associated lipids |
| Insulin Resistance | D007333 | 99 associated lipids |
| Atherosclerosis | D050197 | 85 associated lipids |
| Alzheimer Disease | D000544 | 76 associated lipids |
| Colitis | D003092 | 69 associated lipids |
| Pain | D010146 | 64 associated lipids |
| Fatty Liver | D005234 | 48 associated lipids |
| Peritonitis | D010538 | 38 associated lipids |
| Lung Diseases | D008171 | 37 associated lipids |
| Burns | D002056 | 34 associated lipids |
Resolvin d1
Resolvin d1 is a lipid of Fatty Acyls (FA) class.
Cross Reference
There are no associated biomedical information in the current reference collection.
Current reference collection contains 305 references associated with Resolvin d1 in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.
Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.
Here are additional resources we collected from PubChem and MeSH for Resolvin d1
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with Resolvin d1
PubChem Biomolecular Interactions and Pathways
All references with Resolvin d1
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Lee Y et al. | Analysis of endogenous lipids during intestinal wound healing. | 2017 | PLoS ONE | pmid:28800645 |
| Lippestad M et al. | Resolvin D1 Increases Mucin Secretion in Cultured Rat Conjunctival Goblet Cells via Multiple Signaling Pathways. | 2017 | Invest. Ophthalmol. Vis. Sci. | pmid:28892824 |
| Mottola G et al. | Aspirin-triggered resolvin D1 attenuates PDGF-induced vascular smooth muscle cell migration via the cyclic adenosine monophosphate/protein kinase A (cAMP/PKA) pathway. | 2017 | PLoS ONE | pmid:28362840 |
| Eickmeier O et al. | Pro-resolving lipid mediator Resolvin D1 serves as a marker of lung disease in cystic fibrosis. | 2017 | PLoS ONE | pmid:28158236 |
| Liu Y et al. | Resolvin D1 protects against inflammation in experimental acute pancreatitis and associated lung injury. | 2016 | Am. J. Physiol. Gastrointest. Liver Physiol. | pmid:26702138 |
| Abdulnour RE et al. | Aspirin-triggered resolvin D1 is produced during self-resolving gram-negative bacterial pneumonia and regulates host immune responses for the resolution of lung inflammation. | 2016 | Mucosal Immunol | pmid:26647716 |
| Berrueta L et al. | Stretching Impacts Inflammation Resolution in Connective Tissue. | 2016 | J. Cell. Physiol. | pmid:26588184 |
| Kim N et al. | Specialized proresolving mediators (SPMs) inhibit human B-cell IgE production. | 2016 | Eur. J. Immunol. | pmid:26474728 |
| Easley JT et al. | AT-RvD1 combined with DEX is highly effective in treating TNF-α-mediated disruption of the salivary gland epithelium. | 2016 | Physiol Rep | pmid:27694530 |
| Titos E et al. | Signaling and Immunoresolving Actions of Resolvin D1 in Inflamed Human Visceral Adipose Tissue. | 2016 | J. Immunol. | pmid:27647830 |